Clinical Trial Update: Safety Study of CALAA-01 to Treat Solid Tumor Cancers [Phase 1]

View source ↗

Summary

Phase 1 safety study of CALAA-01 in solid tumor cancers has been terminated, according to a clinical trials update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumor

Drugs mentioned

• CALAA-01

Snippet

Sponsor: Calando Pharmaceuticals | Conditions: Cancer, Solid Tumor | Phase 1 | Status: TERMINATED